H
Hoth Therapeutics D
D
HOTH
1.58000
USD
-0.09
(-5.11%)
مغلق
حجم التداول
14,286
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
20,949,263
الأخبار المقالات
العنوان: Hoth Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for thetreatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).